Concepedia
Statistics
Publications
163
Citations
11.4K
H-Index
54
Active since
1981
Affiliations
KU Leuven(Current)
Universitair Ziekenhuis Leuven
Université Paris Cité
Hadassah Medical Center
University of Milan
K. De Boeck is an author at KU Leuven specializing in cystic fibrosis, medicine, and pulmonology.
Publications per year
1981–2024
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
John P. Clancy, Steven M. Rowe, Frank J. Accurso et al. · Thorax · 2011 · 496 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +16
Recommendations for the classification of diseases as CFTR-related disorders
Cristina Bombieri, Mireille Claustres, K. De Boeck et al. · Journal of Cystic Fibrosis · 2011 · 421 citations · Full text
Medicine, Clinical Sciences, Molecular Medicine +11
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
K. De Boeck, À. Munck, Seth Walker et al. · Journal of Cystic Fibrosis · 2014 · 386 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +14
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Eitan Kerem, Michael W. Konstan, K. De Boeck et al. · The Lancet Respiratory Medicine · 2014 · 335 citations · Full text
Medicine, Molecular Medicine, Pharmacotherapy +9
1–5 of 163